Coherus Oncology, Inc. (CHRS)

Coherus Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	216.89	125.99	102.89	63.55	417.2	541.16
Short-Term Investments	20.74	-	14.86	128.13	-	-
Cash & Short-Term Investments	237.64	125.99	117.75	191.68	417.2	541.16
Cash Growth	49.23%	7.00%	-38.57%	-54.05%	-22.91%	204.59%
Accounts Receivable	5.11	111.32	260.52	109.96	123.02	157.05
Other Receivables	114.53	11.01	-	-	-	-
Receivables	119.64	122.33	260.52	109.96	123.02	157.05
Inventory	4.51	70.09	62.61	38.79	37.64	44.23
Prepaid Expenses	18.42	23.17	34.76	40.8	24.46	25.04
Total Current Assets	380.21	341.58	475.63	381.23	602.32	767.48
Property, Plant & Equipment	1.91	7.36	11.03	14.44	16.01	10.11
Goodwill	-	-	0.94	0.94	0.9	0.94
Other Intangible Assets	52.31	53.65	70.73	4.99	2.66	2.62
Other Long-Term Assets	5.04	45.95	71.27	79.24	57.44	60.5
Total Assets	439.46	448.53	629.6	480.85	679.33	841.65
Accounts Payable	37.62	28.46	35.22	11.53	16.16	15.2
Accrued Expenses	120.25	227.04	291.11	122.85	145.68	127.32
Current Portion of Long-Term Debt	-	1.15	-	-	-	-
Current Portion of Leases	1.76	1.69	2.15	4.32	3.49	3.13
Other Current Liabilities	104	24.65	3.3	-	-	-
Total Current Liabilities	263.63	282.98	331.77	138.69	165.33	145.65
Long-Term Debt	36.87	292.52	473.37	471.06	408.28	404.02
Long-Term Leases	2.41	3.29	5.33	5.05	7.25	9.95
Long-Term Deferred Tax Liabilities	1.1	1.1	1.1	-	-	-
Other Long-Term Liabilities	15.63	0.63	11.46	3.47	0.75	1.05
Total Liabilities	319.64	580.52	823.03	618.27	581.61	560.68
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,430	1,419	1,386	1,204	1,148	1,044
Retained Earnings	-1,310	-1,551	-1,580	-1,342	-1,050	-762.75
Comprehensive Income & Other	-0.28	-0.28	-0.25	-0.25	-0.27	-0.27
Total Common Equity	119.83	-131.99	-193.43	-137.42	97.73	280.97
Shareholders' Equity	119.83	-131.99	-193.43	-137.42	97.73	280.97
Total Liabilities & Equity	439.46	448.53	629.6	480.85	679.33	841.65
Total Debt	41.03	298.65	480.84	480.42	419.02	417.1
Net Cash (Debt)	196.61	-172.66	-363.09	-288.74	-1.83	124.06
Net Cash Per Share	1.70	-1.50	-3.86	-3.72	-0.02	1.49
Filing Date Shares Outstanding	116.23	115.9	112.71	79.61	77.28	72.79
Total Common Shares Outstanding	116.22	115.61	112.22	78.85	76.93	72.51
Working Capital	116.58	58.6	143.86	242.54	437	621.83
Book Value Per Share	1.03	-1.14	-1.72	-1.74	1.27	3.87
Tangible Book Value	67.52	-185.64	-265.1	-143.35	94.16	277.41
Tangible Book Value Per Share	0.58	-1.61	-2.36	-1.82	1.22	3.83
Machinery	15.21	18.07	17.73	17.39	16.04	18.57
Construction In Progress	-	-	-	0.7	0.39	0.31
Leasehold Improvements	5.75	5.75	5.75	6.2	5.94	5.83

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q